Back to SPPI Stock Lookup

Spectrum Pharma (SPPI) – Press Releases

Apr 30, 2015 07:00 AM Spectrum Pharmaceuticals Announces First Quarter 2015 Financial Results Teleconference and Webcast
Mar 30, 2015 07:00 AM Spectrum Pharmaceuticals Presents New Data on EVOMELATM (CE-Melphalan), at the Annual Meeting of the American Pharmacists Association (APhA) in San Diego, Highlighting Stability
Mar 13, 2015 07:00 AM Spectrum Pharmaceuticals Reports Robust Clinical Data and Strong 2014 Financial Results
Mar 11, 2015 07:00 AM Four Oncology Key Opinion Leaders to Present at Spectrum Pharmaceuticals’ Analyst Day on Friday, March 13th
Mar 9, 2015 07:00 AM Spectrum Pharmaceuticals Announces FDA's Acceptance of NDA Filing for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan
Mar 4, 2015 07:00 AM Spectrum Pharmaceuticals In-Licenses Poziotinib, a Novel pan-HER Inhibitor With Clinical Activity in Several Solid Tumors, From Hanmi Pharmaceuticals
Feb 20, 2015 07:00 AM Spectrum Pharmaceuticals to Present Corporate Update at the 2015 RBC Capital Markets' Global Healthcare Conference on February 24th
Feb 17, 2015 07:00 AM Spectrum Pharmaceuticals Announces Fourth Quarter 2014 Financial Results and Analyst Day
Feb 12, 2015 07:00 AM Spectrum Pharmaceuticals Highlights Clinical Data for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan at the 2015 BMT Tandem Meeting

Back to SPPI Stock Lookup